SCIENTIFIC POSTER
Leverage automated workflows to enable complex organoid assays
3D organoids are increasingly popular in drug discovery and disease modeling, however, their complexity can be a hurdle for their wider adoption in research and drug screening.
Here, we describe how to alleviate the hurdles of the labor-intensive manual protocols by using automation. Accordingly, we developed automation protocols for the entire 3D culture workflow and increase the throughput and accuracy of organoid assays.
The automated methods utilize an integrated workcell, providing automated cell plating, culture monitoring, media exchange, and a high-content imaging. In addition, the method allows automation of compound addition, cell staining, and end point assays.
Learn more about the systems behind the methods:
More Great Resources
![3D Biology: The paradigm shift in next-generation drug discovery [Interactive infographic]](./media_1c761770b532a641e8ebb023c3aebc9edda9ae595.jpeg?width=750&format=jpeg&optimize=medium)
Blog
3D Biology: The paradigm shift in next-generation drug discovery [Interactive infographic]
The drug discovery landscape is changing. Bringing a drug to market has historically been time-consuming and costly, with…
Application Note
Understanding organoid morphology: a study to assess organoid size and cell count from 3D…
Compound library screens using 2D monolayer cancercell lines are commonly performed in the pharmaceutical industry, to…
Videos & Webinars